Please try another search
Proactive Investors - AstraZeneca PLC (LSE:LON:AZN) is acquiring Canada's Fusion Pharmaceuticals for $2.4 billion, in a bid to effectively 'keep up with Joneses' as it seeks to challenge Novartis,...
Equity research firm Jefferies initiated coverage on BeiGene (NASDAQ:BGNE) with a "buy" rating and a price target of $287. BeiGene is an oncology company with a strong presence in China, and...
Investing.com - European stock markets drifted in subdued trading Tuesday, with investors looking forward to more corporate earnings while worries over the Chinese economic recovery continue to...
Investing.com - European stock markets drifted lower Tuesday, with losses in the banking sector weighing ahead of the start of big tech earnings season on Wall Street. At 04:05 ET (08:05 GMT), the DAX...
By Scott Kanowsky Investing.com -- Shares in Novartis AG (SIX:NOVN) saw their biggest intraday climb in fifteen months on Monday after the pharmaceutical giant announced positive results from a...
By Scott Kanowsky Investing.com -- Novartis AG (SIX:NOVN) has confirmed that the Swiss competition commission (COMCO) has visited the Basel headquarters of the drugmaker in connection to an...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review